May 28, 2026 | 8:00 AM – 4:30 PM
Chicago, IL
OncLive® is proud to present the National Fellows Forum: Lung Cancer. This forum offers fellows the opportunity to discuss abstracts and engage with peers and leading experts in the oncology community. We will select 50-75 fellows to attend a one-day, all-expenses-paid trip focused on learning and networking

BENEFITS:
✅ Complimentary Stay – Enjoy 1 hotel night to attend the forum
✈️ Travel Assistance – Round-trip fare to Chicago, IL
🤝 Unparalleled Networking – Connect with renowned faculty and peers in the field

Oncology fellows are invited to submit their research abstract for consideration by Tuesday, April 28, 2026, at 11:59 PM ET. Please note only one submission per individual and please adhere to the guidelines below.

  • All abstracts must be submitted online, in PDF version.
  • Your abstract should be a short description of your research/work in lung Cancer, containing all the elements necessary to define your goals and results to the reader.
  • Authors will be required to disclose all financial relationships helping to ensure quality and unbiased presentations
  • All categories pertaining to the subject matter are welcomed. Abstracts are for any project in which there has been data analyzed and not for a presentation of an ongoing project without analyzable data or with results pending.

Note: Abstract submissions must reflect completed research. Submissions of previously presented research are permitted.

Our board of faculty will evaluate the abstracts based on the following criteria: novelty of the research, significance of the findings, relevance to lung cancer, and clarity. Incomplete abstracts will not be accepted.

Notification of acceptance, or regret, will be delivered via e-mail to fellows by Mid May. Please note the faculty will determine if your abstract submission will be an oral or poster presentation. Our agenda plans for approximately 15 oral presentations during the designated meeting dates.

Abstract Format
  • The title of the abstract should be brief, objectively describing the study. Do not use non-standard abbreviations and commercial names (generic names only).
  • Capitalize only the first word and any proper nouns.
  • Only one submission per fellow.
  • Abstracts are permitted to have one figure or table included in submission
  • Abstracts limited to 2500 characters (abstract body, including spaces).
  • Abstracts should be structured in such a way as to include the following 4 sections:
    • Objectives -- What was the intent or goal of the study? What did you want to learn?
    • Methods -- What was the trial design? What was the sample? What instruments were used? How were data collected and analyzed?
    • Results -- What were the findings?
    • Conclusions -- What do the findings mean?

Abstract Questions

Please submit any questions pertaining to submissions to Sarah Nemshick snemshick@mjhlifesciences.com

Question Title

* 1. SUBMITTER/AUTHOR DETAILS

Question Title

* 2. Submit Abstract

Question Title

* 3. Submit a copy of your CV.

Join the OncLive National Fellows Forum® LinkedIn Group!
Stay connected with your peers and continue the conversation. Click below to request to join:

Request to Join the OncLive National Fellows Forum® LinkedIn Group🔗

Question Title

* 4. Have you requested to join the group?

( Privacy & Cookie Notice

T